Product category:
Analogue and Mixed Signal ICs
News Release from: AMI Semiconductor | Subject: Medical semiconductors
Edited by the Electronicstalk Editorial
Team on 08 November 2006
Medical semiconductors help treat
epilepsy
Implantable medical device company NeuroPace has leveraged AMI Semiconductor's medical semiconductor expertise for an implantable epilepsy device, the Responsive Neurostimulator (RNS) system.
Implantable medical device company NeuroPace has leveraged AMI Semiconductor's medical semiconductor expertise for an implantable epilepsy device, the Responsive Neurostimulator (RNS) system NeuroPace's RNS is specifically designed for the treatment of medically refractory partial onset epilepsy and includes implantable and external products, accessories and tools
This article was originally published on Electronicstalk on 26 Mar 2001 at 8.00am (UK)
Related stories
Clock generators for embedded communications
AMI Semiconductor (AMIS) has expanded its clock generator product line with a broad family of low-cost 1- and 2-phase-lock loop (PLL) clock ICs.
Clock generator saves space in portable designs
AMI Semiconductor (AMIS) has introduced a low-cost clock generator that will save space and reduce component count in high-performance MPEG-2 applications such as DVD players.
In addition to treating epilepsy, responsive neurostimulation holds the promise of treating other disabling medical disorders that impact the quality of life for millions of patients around the world.
In treating epilepsy, the RNS is designed to detect abnormal electrical activity in the brain and respond by delivering electrical stimulation to normalise brain activity before the patient experiences seizure symptoms.
The RNS is implanted in the cranium and connected to one or two leads that are implanted near the patient's seizure focus.
Further reading
Extended-temperature interface for AS-i bus
AMI Semiconductor (AMIS) has expanded its family of reprogrammable interface ICs certified for Actuator Sensor-interface (AS-i) bus applications by launching an extended temperature device.
PCI core migrates FPGA designs painlessly
Designers using high-density, advanced FPGAs with embedded PCI cores can now cost-effectively and easily transition to an ASIC for volume production.
By targeting electrical stimulation to specific nervous system sites, the RNS is designed to suppress seizures and minimise the patient's use of anti-epileptic medication and the side effects commonly associated with these medications.
"We evaluated the major participants in the implantable medical semiconductor design business", said Frank Fischer, CEO at NeuroPace.
"AMIS has the proven expertise in development of advanced mixed-signal technologies for innovative medical applications".
"The company's production capabilities and experience are an excellent fit for the critical technical requirements and support necessary for our RNS system".
"The implantable neurostimulation device market is a key strategic focus for our medical semiconductor solutions", said Robert Tong, Senior Vice President of Medical and Wireless Products for AMIS.
"Based on our research and the volume of new technology solutions being developed, we believe this is a market that will grow exponentially over the next few years".
"It offers high potential growth for AMIS, who has been developing and manufacturing mixed-signal and wireless solutions for implantable devices for more than 10 years".
"We are very aware of the constraints that must be considered when designing semiconductors for implantation in the human body and we are excited to partner with an innovator like NeuroPace to use our knowledge to help improve the lives of those afflicted with epilepsy".
NeuroPace is currently sponsoring an FDA approved investigational study of the implantable RNS system to suppress seizures in patients with drug refractory epilepsy.
• AMI Semiconductor: contact details and other news
• Email this article to a colleague
• Register for the free Electronicstalk email newsletter
• Electronicstalk Home Page

